Magnetic resonance imaging (MRI) is a routine, albeit expensive, test used in lobular breast cancer. Unfortunately, the high cost means that some DHBs struggle to meet the MRI demand. Some doctors also suspect that it may not make a difference to patient outcomes in lobular breast cancer.
Dr Kwok and his team will evaluate the efficacy of MRI as a diagnostic tool for patients with lobular breast cancer. The study will compare the accuracy of MRI against other cancer staging tests. They will also evaluate the impact of use of MRI on long term outcomes for patients.